Aakaar Medical Technologies
70.80
-3.70(-4.97%)
Market Cap₹100.34 Cr
PE Ratio-
Company Performance:
1D-4.97%
1M+29.91%
6M-5.47%
1Y-0.63%
5Y-0.63%
View Company Insightsright
More news about Aakaar Medical Technologies
15May 26
Aakaar Medical Technologies Updates Code of Fair Disclosure Under SEBI Insider Trading Regulations
Aakaar Medical Technologies Limited's Board approved the revision of its Code of Practices and Procedures for Fair Disclosure of UPSI on May 14, 2026, under Regulation 8(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The policy, originally adopted on December 19, 2024 and now carrying Revision 01/2026, sets out principles for uniform UPSI dissemination, analyst interactions, compliance officer duties, and digital database maintenance. An accompanying Annexure A outlines the Policy for Determination of Legitimate Purposes for sharing UPSI. The revised code is publicly available on the company's official website.
 no imag found
10May 26
Aakaar Medical Technologies Submits Structured Digital Database Compliance Certificate for Financial Year Ended March 31, 2026
Aakaar Medical Technologies Limited submitted its SDD compliance certificate for the financial year ended March 31, 2026, to the National Stock Exchange of India on May 09, 2026. Certified by Devendra V Deshpande of DVD & Associates, the certificate confirms all 52 required UPSI events were captured and no non-compliance was observed. A temporary technical issue in the SDD during February 2026 was resolved promptly, with no data loss or integrity concerns, and the matter was noted by the Audit Committee.
 no imag found
08May 26
Aakaar Medical Technologies Schedules H2 & FY26 Earnings Call for May 15, 2026
Aakaar Medical Technologies Limited has scheduled its H2 & FY26 earnings conference call for May 15, 2026, at 4:30 PM IST, following the Board's approval of audited financial results for the year ended March 31, 2026. The call, organised by Go India Advisors, will feature Founder & MD Dilip Meswani, CEO Rahul Sawakhande, and CFO Rakesh Parekh, with pre-registration mandatory for dial-in access. The intimation was filed under SEBI Regulation 30 and submitted to NSE on May 07, 2026.
 no imag found
1 Year Returns:-0.63%
Industry Peers
Dabur India
424.15
(-0.12%)
Colgate Palmolive
1,999.50
(-0.24%)
Gillette
7,763.00
(+0.73%)
Cupid
137.10
(+3.01%)
Emami
384.80
(-1.51%)
Mamaearth
416.10
(-0.23%)
Bajaj Consumer Care
552.05
(-1.21%)
Anondita Medicare
1,219.90
(+2.90%)